Evaluation of a novel chimeric B cell epitope-based vaccine against mastitis induced by either Streptococcus agalactiae or Staphylococcus aureus in mice

Clinical and Vaccine Immunology

Volumn 18, Issue 6, 2011, Pages 893-900

  Xu, Haiyang ^a   Hu, Changmin ^a   Gong, Rui ^a   Chen, Yingyu ^a   Ren, Ningning ^a   Xiao, Ganwen ^a   Xie, Qian ^a   Zhang, Minmin ^a   Liu, Qin ^a   Guo, Aizhen ^a   Chen, Huanchun ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; EPITOPE; HYBRID PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INACTIVATED VACCINE; MINERAL OIL; RECOMBINANT PROTEIN; SURFACE IMMUNOGENIC PROTEIN CLUMPING FACTOR A FUSION PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNIZATION; MASTITIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPSONIZATION; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; VACCINE PRODUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL LOAD; BACTERIAL PROTEINS; CATTLE; COAGULASE; EPITOPES, B-LYMPHOCYTE; FEMALE; HISTOCYTOCHEMISTRY; IMMUNOGLOBULIN G; MAMMARY GLANDS, ANIMAL; MASTITIS; MICE; MICE, INBRED BALB C; MINERAL OIL; OPSONIN PROTEINS; PHAGOCYTOSIS; RECOMBINANT PROTEINS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; VACCINES, SYNTHETIC;

EID: 79958001805     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00066-11     Document Type: Article

References (35)

1. Barlow, D. J., M. S. Edwards, and J. M. Thornton. 1986. Continuous and discontinuous protein antigenic determinants. Nature 322:747-748.
2. Benjamin, D. C., et al. 1984. The antigenic structure of proteins: a reappraisal. Annu. Rev. Immunol. 2:67-101.
3. Brodeur, B. R., et al. 2000. Identification of group B streptococcal Sip protein, which elicits cross-protective immunity. Infect. Immun. 68:5610-5618.
4. Brouillette, E., and F. Malouin. 2005. The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse. Microbes Infect. 7:560-568.
5. Brouillette, E., et al. 2002. DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureus. Vaccine 20:2348-2357. (Pubitemid 34497046)
6. Castagliuolo, I., et al. 2006. Mucosal genetic immunization against four adhesins protects against Staphylococcus aureus-induced mastitis in mice. Vaccine 24:4393-4402.
7. De Groot, A. S., et al. 2005. Developing an epitope-driven tuberculosis (TB) vaccine. Vaccine 23:2121-2131. (Pubitemid 40341438)
8. Diarra, M. S., et al. 2003. Lactoferrin against Staphylococcus aureus mastitis. Lactoferrin alone or in combination with penicillin G on bovine polymorphonuclear function and mammary epithelial cells colonisation by Staphylococcus aureus. Vet. Immunol. Immunopathol. 95:33-42. (Pubitemid 37102760)
9. Emini, E. A., J. V. Hughes, D. S. Perlow, and J. Boger. 1985. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J. Virol. 55:836-839. (Pubitemid 16254565)
10. Gong, R., et al. 2010. Evaluation of clumping factor A binding region A in a subunit vaccine against Staphylococcus aureus-induced mastitis in mice. Clin. Vaccine Immunol. 17:1746-1752.
11. Hogan, J. S., K. L. Smith, D. A. Todhunter, and P. S. Schoenberger. 1992. Field trial to determine efficacy of an Escherichia coli J5 mastitis vaccine. J. Dairy Sci. 75:78-84.
12. Hu, C., R. Gong, A. Guo, and H. Chen. 2010. Protective effect of ligand-binding domain of fibronectin-binding protein on mastitis induced by Staphylococcus aureus in mice. Vaccine 28:4038-4044.
13. Jameson, B. A., and H. Wolf. 1988. The antigenic index: a novel algorithm for predicting antigenic determinants. Comput. Appl. Biosci. 4:181-186.
14. Karplus, P. A., and G. E. Schultz. 1985. Prediction of chain flexibility in proteins. Immunology 72:212-213.
15. Keefe, G. P. 1997. Streptococcus agalactiae mastitis: a review. Can. Vet. J. 38:429-437.
16. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
17. Lee, J. W., et al. 2005. Effect of a trivalent vaccine against Staphylococcus aureus mastitis lymphocyte subpopulations, antibody production, and neutrophil phagocytosis. Can. J. Vet. Res. 69:11-18.
18. Leitner, G., et al. 2003. Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. II. Field trial. Vet. Immunol. Immunopathol. 93:153-158.
19. Liu, Z., et al. 2007. Isolation, identification and analysis of drug resistance of bovine mastitis-causing pathogens from Hubei province. China Dairy Cattle 7:35-37.
20. Martin, D., et al. 2002. Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein. Infect. Immun. 70:4897-4901.
21. Maurer, M., and E. von Stebut. 2004. Macrophage inflammatory protein-1. Int. J. Biochem. Cell Biol. 36:1882-1886.
22. Miles, K., et al. 2009. Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins. J. Immunol. 183:2122-2132.
23. Nour El-Din, A. N., L. Shkreta, B. G. Talbot, M. S. Diarra, and P. Lacasse. 2006. DNA immunization of dairy cows with the clumping factor A of Staphylococcus aureus. Vaccine 24:1997-2006. (Pubitemid 43255140)
24. Peacock, S. J., et al. 2002. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect. Immun. 70:4987-4996.
25. Pyörälä, S. 2002. New strategies to prevent mastitis. Reprod. Domest. Anim. 37:211-216.
26. Rennermalm, A., et al. 2001. Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat. Vaccine 19:3376-3383.
27. Rioux, S., et al. 2001. Localization of surface immunogenic protein on group B Streptococcus. Infect. Immun. 69:5162-5165. (Pubitemid 32674504)
28. Rydell-Törmänen, K., L. Uller, and J. S. Erjefält. 2006. Direct evidence of secondary necrosis of neutrophils during intense lung inflammation. Eur. Respir. J. 28:268-274.
29. Schlageter, A. M., and T. R. Kozel. 1990. Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide. Infect. Immun. 58:1914-1918.
30. Sette, A., and J. Fikes. 2003. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr. Opin. Immunol. 15:461-470.
31. Shkreta, L., B. G. Talbot, M. S. Diarra, and P. Lacasse. 2004. Immune responses to a DNA/protein vaccination strategy against Staphylococcus aureus induced mastitis in dairy cows. Vaccine 23:114-126.
32. Strindelius, L., L. Degling Wikingsson, and I. Sjöholm. 2002. Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination. Infect. Immun. 70:1434-1442.
33. Talbot, B. G., and P. Lacasse. 2005. Progress in the development of mastitis vaccines. Livestock Prod. Sci. 98:101-113.
34. Wei, J. C., et al. 2010. Design and evaluation of a multi-epitope peptide against Japanese encephalitis virus infection in BALB/c mice. Biochem. Biophys. Res. Commun. 396:787-792.
35. Zhu, D., et al. 2008. A DNA fusion vaccine induces bactericidal antibodies to a peptide epitope from the PorA porin of Neisseria meningitidis. Infect. Immun. 76:334-338.